News from sophiris bio, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 05, 2013, 17:00 ET

Sophiris Bio to Present at the Stifel Healthcare Conference

SAN DIEGO AND VANCOUVER, Sept. 5, 2013 /PRNewswire/ - Sophiris Bio Inc. (NASDAQ: SPHS, TSX: SHS) (the "Company" or "Sophiris"), a...

Aug 23, 2013, 09:38 ET

Sophiris Bio Closes $65 Million Public Offering

SAN DIEGO and VANCOUVER, Aug. 23, 2013 /PRNewswire/ - Sophiris Bio Inc. (NASDAQ: SPHS, TSX: SHS) (the "Company" or "Sophiris"), a...

Aug 16, 2013, 09:28 ET

Sophiris Bio Prices its Previously Announced Public Offering of Common Shares

SAN DIEGO and VANCOUVER, Aug. 16, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company" or "Sophiris"), a biopharmaceutical...

Aug 12, 2013, 16:05 ET

Sophiris Bio Announces Share Consolidation

Share Consolidation in Anticipation of Listing on the NASDAQ Stock Market SAN DIEGO AND VANCOUVER, Aug. 12, 2013 /PRNewswire/ - Sophiris Bio...

Aug 05, 2013, 17:28 ET

Sophiris Bio Reports Second Quarter Financial Results and Recent Key Operational Highlights

SAN DIEGO AND VANCOUVER, Aug. 5, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company" or "Sophiris"), a biopharmaceutical...

Jul 15, 2013, 07:00 ET

Sophiris Bio Announces an Addition to its Board of Directors

SAN DIEGO, CA and VANCOUVER, July 15, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company" or "Sophiris"), a...

Jul 12, 2013, 16:00 ET

Sophiris Bio Announces Changes to Board of Directors

SAN DIEGO & VANCOUVER, July 12, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company" or "Sophiris"), a biopharmaceutical...

Apr 30, 2013, 17:00 ET

Sophiris Bio Reports First Quarter Financial Results and Recent Key Operational Highlights

SAN DIEGO, CA and VANCOUVER, April 30, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company" or "Sophiris"), a urology...

Feb 18, 2013, 15:35 ET

Correction - Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ

This release has been updated to correct the expected start date of the first pivotal trial for PRX302 to "in the first half of 2013." SAND...

Feb 15, 2013, 17:24 ET

Sophiris Bio Inc. Files Registration Statement for Proposed Initial U.S. Public Offering on the NASDAQ

SAN DIEGO, CA and VANCOUVER, BC, Feb. 15, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) ("Sophiris" or the "Company"), a...

Feb 13, 2013, 17:00 ET

Sophiris Bio Reports Fourth Quarter and Year-End 2012 Financial Results and Key Operational Highlights

SAN DIEGO, CA and VANCOUVER, Feb. 13, 2013 /PRNewswire/ - Sophiris Bio Inc. (Sophiris, TSX: SHS) (the "Company"), a biopharmaceutical company...

Nov 12, 2012, 17:00 ET

Sophiris Bio Reports Third Quarter Financial Results and Recent Key Operational Highlights

SAN DIEGO, CA and VANCOUVER, BC, Nov. 12, 2012 /PRNewswire/ - Sophiris Bio Inc. (TSX:SHS) ("Sophiris"), a urology company developing a...

Nov 06, 2012, 16:00 ET

Sophiris Bio to Present at the Lazard Capital Markets 9th Annual Healthcare Conference

SAN DIEGO, CA and VANCOUVER, BC, Nov. 6, 2012 /PRNewswire/ - Sophiris Bio Inc. (TSX: SHS), a urology company developing a late-stage, highly...

Oct 09, 2012, 07:00 ET

Sophiris Bio Announces 12 Month Follow-Up Data from Phase 2b TRIUMPH Clinical Trial of PRX302 in Patients with Benign Prostatic Hyperplasia

Single administration of PRX302 as a short outpatient procedure provided sustained benefit over 12 months SAN DIEGO, CA and VANCOUVER, Oct. 9,...

Oct 02, 2012, 17:00 ET

Sophiris Bio to Present at the 11th Annual BIO Investor Forum

SAN DIEGO, CA and VANCOUVER, Oct. 2, 2012 /PRNewswire/ - Sophiris Bio Inc. (TSX: SHS), a urology company developing a late-stage, highly targeted...

Aug 31, 2012, 07:00 ET

Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration

SAN DIEGO, CA and VANCOUVER, Aug. 31, 2012 /PRNewswire/ - Sophiris Bio Inc. (TSX: SHS) today announced data from its transrectal safety study, in...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge